Satyam Generic Pharma Private Limited
About Satyam Generic Pharma Private Limited
Data last updated:
Satyam Generic Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 November 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2000PTC129773. Its GSTIN is 27AAHCS0020L1ZI (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹9.43 Lakh. It is led by directors including Dhroov Dinesh Singh and Dinesh Amar Bahadur Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101/A Ruchi Apartmentsr N P Park Bhayander (East), Thane, Maharashtra, India – 401105.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.48 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹13.63 Lakh (net margin 0.2%) and EBITDA of ₹1.77 Cr (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹5.33 Cr on record. Court records list 35 cases involving the company, including 33 filed by the company and 2 filed against it; 30 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address101/A Ruchi Apartmentsr N P Park Bhayander (East), Thane, Maharashtra, India – 401105
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Satyam Generic Pharma Private Limited
The main business activity of Satyam Generic Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Satyam Generic Pharma Private Limited FY 2025 filings available
Satyam Generic Pharma Private Limited reported revenue of ₹64.48 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Satyam Generic Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 16% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Satyam Generic Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.77 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13.63 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Satyam Generic Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Satyam Generic Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Satyam Generic Pharma Private Limited
Satyam Generic Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Compass Enterprises Private Limited | ₹65.78 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Rajahmundry, Andhra Pradesh, India |
| Transworld Medical Corporation Private Limited | ₹65.39 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Foray Pharma Distributors Private Limited | ₹65.28 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Mumbai, Maharashtra, India |
| R.S. Enterprises (Bangalore) Private Limited | ₹64.99 Cr (FY 2024) | •••• | •••• | -41.0% | •••• | Bangalore, Karnataka, India |
| Tulsyan Healthcare Private Limited | ₹64.8 Cr (FY 2024) | •••• | •••• | 119.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Satyam Generic Pharma Private Limited this company | ₹64.48 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Thane, Maharashtra, India |
| Entero R.S. Enterprises Private Limited | ₹64.36 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Bangalore, Karnataka, India |
| Pradip Health Care Private Limited | ₹64.21 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Bilaspur, Chhattisgarh, India |
| Shanbalaji Pharma Distributors Private Limited | ₹64.16 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Chennai, Tamil Nadu, India |
| SKJ Healthcare Private Limited | ₹63.89 Cr (FY 2024) | •••• | •••• | 123.0% | •••• | Ahmedabad, Gujarat, India |
| A.P.Fine Chem Private Limited | ₹63.86 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Hyd.Ap, Telangana, India |
Peers are the five companies nearest above and the five nearest below Satyam Generic Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Satyam Generic Pharma Private Limited
Satyam Generic Pharma Private Limited is audited by S M BHAT & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S M BHAT & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Satyam Generic Pharma Private Limited
Satyam Generic Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhroov Dinesh Singh Also directs: Sundaram Pharma Private Limited | Director | 15 Mar 2022 | 4 Years 6 Months | Current |
| Dinesh Amar Bahadur Singh | Director | 27 Nov 2000 | 25 Years 10 Months | Current |
| Brijesh Amar Bahadur Singh Also directs: Chandra-Corbox Packaging Private Limited, Sundaram Pharma Private Limited, Geminova Pharmaceuticals Private Limited and 1 more | Director | 27 Nov 2000 | 25 Years 10 Months | Current |
Ownership and Shareholding of Satyam Generic Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Satyam Generic Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2012 | Others | ₹2.9 Cr | Open |
| 30 Jul 2009 | Ing Vysya Bank Limited | ₹1.25 Cr | Open |
| 18 Nov 2006 | Indusind Bank Limited | ₹75 Lakh | Open |
| 11 Apr 2002 | Central Bank of India | ₹43 Lakh | Open |
Total charge records: 4 View all charges
Legal Cases of Satyam Generic Pharma Private Limited
Satyam Generic Pharma Private Limited has 35 court cases on record: 33 filed by Satyam Generic Pharma, 2 filed against it. 30 cases are pending and 5 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 35 | 2 | 30 |
Cases on record (5 of 35)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Laxmi Pharma | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
Full case history
All 35 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Satyam Generic Pharma Private Limited
Employment history and EPFO contributions of people linked to Satyam Generic Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Satyam Generic Pharma Private Limited
Satyam Generic Pharma has one previous CIN (Corporate Identification Number): U51397MH2004PTC129773. The current CIN is U51397MH2000PTC129773, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397MH2000PTC129773 | Current |
| U51397MH2004PTC129773 | Previous |
Recent Activity on Satyam Generic Pharma Private Limited
Satyam Generic Pharma Private Limited has 5 board changes on record since 2000: 3 appointments and 2 cessations. The latest: Amar Bahadur Chandrabali Singh ceased to be Director on 30 Aug 2023.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Satyam Generic Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Satyam Generic Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Satyam Generic Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Satyam Generic Pharma Private Limited
Satyam Generic Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCS0020L1ZI | Maharashtra | Active | 01 Jul 2017 |
| 27AAQFS3897P1ZW | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Satyam Generic Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyam Generic Pharma Private Limited
Satyam Generic Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 November 2000 (26+ years old) and is registered under CIN U51397MH2000PTC129773.
Satyam Generic Pharma reported revenue of ₹64.48 Cr for FY 2025 (up 16% YoY).
Satyam Generic Pharma has 3 current directors:
- Dhroov Dinesh Singh - Director
- Dinesh Amar Bahadur Singh - Director
- Brijesh Amar Bahadur Singh - Director
Satyam Generic Pharma reported a net profit of ₹13.63 Lakh (net margin 0.2%) and EBITDA of ₹1.77 Cr (EBITDA margin 2.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Satyam Generic Pharma is 18% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Satyam Generic Pharma is 27AAHCS0020L1ZI, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAQFS3897P1ZW (Maharashtra).
The CIN (Corporate Identification Number) of Satyam Generic Pharma is U51397MH2000PTC129773. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyam Generic Pharma has 35 court cases on record: 33 filed by the company and 2 filed against it. 30 are pending.
Satyam Generic Pharma was incorporated on 27 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Satyam Generic Pharma by revenue are Compass Enterprises Private Limited, Transworld Medical Corporation Private Limited, Foray Pharma Distributors Private Limited, R.S. Enterprises (Bangalore) Private Limited, Tulsyan Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Amar Bahadur Chandrabali Singh ceased to be Director on 30 Aug 2023. Dhroov Dinesh Singh ceased to be Additional Director on 01 Mar 2023. Dhroov Dinesh Singh was appointed as Director on 15 Mar 2022. Satyam Generic Pharma has 5 board changes on record in total.